Acuerdo de conciliación de Adam Minto
Este anuncio contiene información privilegiada a los efectos del artículo 7 del Reglamento de abuso de mercado (UE) 596/2014, ya que forma parte de la legislación nacional del Reino Unido en virtud de la Ley de la Unión Europea (Retirada) de 2018 ("MAR"), y se divulga de acuerdo con las obligaciones de la Compañía bajo el Artículo 17 del MAR.
Para su publicación inmediata
5 de febrero de 2024
revolución belleza grupo plc
("Revolution Beauty", el "Grupo" o la "Compañía")
Acuerdo de conciliación de Adam Minto
Further to the announcement of 13 December 2023, Revolution Beauty (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce that it has reached a settlement agreement with Adam Minto, the Group's co-founder and former Chief Executive Officer ("CEO").
On 2 February 2024, Revolution Beauty and Adam Minto entered into a settlement agreement (the "Acuerdo de solución") relating to the previously announced events that led to the delay of the audit of Revolution Beauty's FY22 results and the suspension of trading of the Group's shares on AIM during Adam Minto's time as CEO, with no admission or acceptance of liability by either party.
Pursuant to the Settlement Agreement, Revolution Beauty and Adam Minto have agreed to the full and final settlement of certain claims between them. In connection with this settlement, Adam Minto will pay Revolution Beauty a settlement sum of £2.9 million (the "Settlement Sum"). The Settlement Sum will be paid in six annual instalments, with the first payment of £483,333.35 due on 28 March 2024 and subsequent equal instalments of £483,333.33 due on 28 March of each calendar year (with the final instalment payable on 28 March 2029). If a Settlement Sum instalment is not paid on time, then interest will be charged at 8% per annum.
Having considered its options and legal advice received, the Board of Directors believe this is a fair settlement for the Company.
Alistair McGeorge, Non-Executive Chairman, commented: "We are very pleased to have reached an agreement with Adam. This, together with the revised payment schedule agreed in December 2023 for the acquisition of Medichem, means we can now focus on the future. We look forward to providing an update on our strategy at our upcoming Capital Markets Event on 8 February 2024".
The signing of the Settlement Agreement constitutes a related party transaction under Rule 13 of the AIM Rules for Companies (the "Reglas de AIM"), by virtue of Adam Minto being a substantial shareholder, as defined in the AIM Rules, of Revolution Beauty, holding approximately 15.34% of the ordinary shares in Revolution Beauty. The directors of Revolution Beauty consider, having consulted with Revolution Beauty's nominated adviser, Liberum Capital Limited, that the terms of this related party transaction are fair and reasonable insofar as shareholders of Revolution Beauty are concerned.
Para más información, por favor póngase en contacto con:
Relaciones con los inversores
Lauren Brindley, directora ejecutiva
Neil Catto, director financiero
Relaciones.Inversores@revolutionbeautyplc.com
Corporativo conjunto Brokers
Liberum (nómada): Edward Thomas / Dru Danford / John More
Tel: + 44 (0) 203 100 2222
Zeus: Nick Cowles/Jamie Peel/Jordan Warburton
Tel: + 44 (0) 161 831 1512
Preguntas de los medios
Consultoría de cabecera: Matt Denham / Will Smith / Antonia Pollock
Tel.: +44 (0) 20 3805 4822
La persona responsable de organizar la publicación de este anuncio en nombre de la Compañía es Lauren Brindley, directora ejecutiva de la Compañía.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.